One of New Zealand’s three licensed cannabis growers is reaching out to other cultivators to partner with them to do "commercial deals".
The invitation comes after yesterday's second reading of the Misuse of Drugs Amendment Bill where the Government made it clear that varieties of cannabis that are already in New Zealand can be used by licensed cultivators in the production of medicinal products.
Helius Therapeutics is a Buy NZ Made certified cannabis company and the country's largest licensed producer.
Paul Manning, executive director says he applauds the Government’s decision to allow licensed producers access to local product.
"This amnesty for local cannabis strains presents an exciting opportunity for these breeders, who can finally step out of the shadows. People with quality genetics can gain lawful income through commercial deals with us, should they choose to contribute their seeds or plantlets," he says.
The company is now calling on local growers to contact the company.
"Owners will receive an upfront Genetics Fee and the opportunity of ongoing royalties for strains that are adopted. We’ll cover the costs of characterising local strains, which will be done in our analytical laboratory," says Mr Manning.
Helius believes the decision to include local cannabis genetics will further New Zealand’s competitive advantage here, and on the world-stage.